Medigene AG (XETRA:MDG1)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MDG1

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MDG1

  • Market Cap€88.430m
  • SymbolXETRA:MDG1
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINDE000A1X3W00

Company Profile

Medigene AG is a Germany based biotechnology company. Along with its subsidiaries, the company is primarily engaged in developing immunotherapies to target various forms and stages of cancer with candidates in clinical and pre-clinical development. The group is focused on the development of personalized T cell-based therapies. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy, DC vaccines, and T-cell-specific monoclonal antibodies. The group operates in the United States, Europe, and Other countries, of which majority of the revenue is derived from operations in the United States.Medigene AG is a biotechnology company engaged in developing immunotherapies to target various forms and stages of cancer with candidates in clinical and pre-clinical development. It is focused on the development of personalized T cell-based therapies.

Latest MDG1 news

Currently there for this company. Visit our news hub for other news .